Krystal Biotech (KRYS) Times Interest Earned (2021)

Krystal Biotech has reported Times Interest Earned for 11 years, with the latest figure at $0.12 in Q2 2026.

• Times Interest Earned for Q2 2026 came in at $0.12, down 63.47% year-over-year; the trailing twelve-month figure through Jun 2026 was $0.42 (down 65.07% YoY), and the FY2025 annual result was $0.54, up 28.47% from the prior year.
• Times Interest Earned slipped to $0.12 in Q2 2026, from $0.19 in the prior quarter.
• Over five years, Times Interest Earned peaked at $0.34 in Q2 2025 and troughed at -$1.65 in Q1 2022.
• A 5-year average of -$0.18 and a median of $0.04 in 2024 frame the typical range for Times Interest Earned.
• The widest annual swing landed in 2022, when Times Interest Earned tumbled 250.84%; it then surged 1125.0% in 2024.
• A 5-year view of Times Interest Earned shows it stood at -$0.85 in 2022, then jumped by 102.56% to $0.02 in 2023, then surged by 1125.0% to $0.26 in 2024, then tumbled by 43.97% to $0.15 in 2025, then declined by 17.1% to $0.12 in 2026.
• Per Business Quant data, the three most recent Times Interest Earned figures were $0.12 in Q2 2026, $0.19 in Q1 2026, and $0.15 in Q4 2025.